Cargando…

Development and validation of a machine learned algorithm to IDENTIFY functionally significant coronary artery disease

INTRODUCTION: Multiple trials have demonstrated broad performance ranges for tests attempting to detect coronary artery disease. The most common test, SPECT, requires capital-intensive equipment, the use of radionuclides, induction of stress, and time off work and/or travel. Presented here are the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Stuckey, Thomas, Meine, Frederick, McMinn, Thomas, Depta, Jeremiah P., Bennett, Brett, McGarry, Thomas, Carroll, William, Suh, David, Steuter, John A., Roberts, Michael, Gillins, Horace R., Lange, Emmanuel, Fathieh, Farhad, Burton, Timothy, Khosousi, Ali, Shadforth, Ian, Sanders, William E., Rabbat, Mark G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481304/
https://www.ncbi.nlm.nih.gov/pubmed/36119746
http://dx.doi.org/10.3389/fcvm.2022.956147
_version_ 1784791234630385664
author Stuckey, Thomas
Meine, Frederick
McMinn, Thomas
Depta, Jeremiah P.
Bennett, Brett
McGarry, Thomas
Carroll, William
Suh, David
Steuter, John A.
Roberts, Michael
Gillins, Horace R.
Lange, Emmanuel
Fathieh, Farhad
Burton, Timothy
Khosousi, Ali
Shadforth, Ian
Sanders, William E.
Rabbat, Mark G.
author_facet Stuckey, Thomas
Meine, Frederick
McMinn, Thomas
Depta, Jeremiah P.
Bennett, Brett
McGarry, Thomas
Carroll, William
Suh, David
Steuter, John A.
Roberts, Michael
Gillins, Horace R.
Lange, Emmanuel
Fathieh, Farhad
Burton, Timothy
Khosousi, Ali
Shadforth, Ian
Sanders, William E.
Rabbat, Mark G.
author_sort Stuckey, Thomas
collection PubMed
description INTRODUCTION: Multiple trials have demonstrated broad performance ranges for tests attempting to detect coronary artery disease. The most common test, SPECT, requires capital-intensive equipment, the use of radionuclides, induction of stress, and time off work and/or travel. Presented here are the development and clinical validation of an office-based machine learned algorithm to identify functionally significant coronary artery disease without radiation, expensive equipment or induced patient stress. MATERIALS AND METHODS: The IDENTIFY trial (NCT03864081) is a prospective, multicenter, non-randomized, selectively blinded, repository study to collect acquired signals paired with subject meta-data, including outcomes, from subjects with symptoms of coronary artery disease. Time synchronized orthogonal voltage gradient and photoplethysmographic signals were collected for 230 seconds from recumbent subjects at rest within seven days of either left heart catheterization or coronary computed tomography angiography. Following machine learning on a proportion of these data (N = 2,522), a final algorithm was selected, along with a pre-specified cut point on the receiver operating characteristic curve for clinical validation. An unseen set of subject signals (N = 965) was used to validate the algorithm. RESULTS: At the pre-specified cut point, the sensitivity for detecting functionally significant coronary artery disease was 0.73 (95% CI: 0.68–0.78), and the specificity was 0.68 (0.62–0.74). There exists a point on the receiver operating characteristic curve at which the negative predictive value is the same as coronary computed tomographic angiography, 0.99, assuming a disease incidence of 0.04, yielding sensitivity of 0.89 and specificity of 0.42. Selecting a point at which the positive predictive value is maximized, 0.12, yields sensitivity of 0.39 and specificity of 0.88. CONCLUSION: The performance of the machine learned algorithm presented here is comparable to common tertiary center testing for coronary artery disease. Employing multiple cut points on the receiver operating characteristic curve can yield the negative predictive value of coronary computed tomographic angiography and a positive predictive value approaching that of myocardial perfusion imaging. As such, a system employing this algorithm may address the need for a non-invasive, no radiation, no stress, front line test, and hence offer significant advantages to the patient, their physician, and healthcare system.
format Online
Article
Text
id pubmed-9481304
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94813042022-09-17 Development and validation of a machine learned algorithm to IDENTIFY functionally significant coronary artery disease Stuckey, Thomas Meine, Frederick McMinn, Thomas Depta, Jeremiah P. Bennett, Brett McGarry, Thomas Carroll, William Suh, David Steuter, John A. Roberts, Michael Gillins, Horace R. Lange, Emmanuel Fathieh, Farhad Burton, Timothy Khosousi, Ali Shadforth, Ian Sanders, William E. Rabbat, Mark G. Front Cardiovasc Med Cardiovascular Medicine INTRODUCTION: Multiple trials have demonstrated broad performance ranges for tests attempting to detect coronary artery disease. The most common test, SPECT, requires capital-intensive equipment, the use of radionuclides, induction of stress, and time off work and/or travel. Presented here are the development and clinical validation of an office-based machine learned algorithm to identify functionally significant coronary artery disease without radiation, expensive equipment or induced patient stress. MATERIALS AND METHODS: The IDENTIFY trial (NCT03864081) is a prospective, multicenter, non-randomized, selectively blinded, repository study to collect acquired signals paired with subject meta-data, including outcomes, from subjects with symptoms of coronary artery disease. Time synchronized orthogonal voltage gradient and photoplethysmographic signals were collected for 230 seconds from recumbent subjects at rest within seven days of either left heart catheterization or coronary computed tomography angiography. Following machine learning on a proportion of these data (N = 2,522), a final algorithm was selected, along with a pre-specified cut point on the receiver operating characteristic curve for clinical validation. An unseen set of subject signals (N = 965) was used to validate the algorithm. RESULTS: At the pre-specified cut point, the sensitivity for detecting functionally significant coronary artery disease was 0.73 (95% CI: 0.68–0.78), and the specificity was 0.68 (0.62–0.74). There exists a point on the receiver operating characteristic curve at which the negative predictive value is the same as coronary computed tomographic angiography, 0.99, assuming a disease incidence of 0.04, yielding sensitivity of 0.89 and specificity of 0.42. Selecting a point at which the positive predictive value is maximized, 0.12, yields sensitivity of 0.39 and specificity of 0.88. CONCLUSION: The performance of the machine learned algorithm presented here is comparable to common tertiary center testing for coronary artery disease. Employing multiple cut points on the receiver operating characteristic curve can yield the negative predictive value of coronary computed tomographic angiography and a positive predictive value approaching that of myocardial perfusion imaging. As such, a system employing this algorithm may address the need for a non-invasive, no radiation, no stress, front line test, and hence offer significant advantages to the patient, their physician, and healthcare system. Frontiers Media S.A. 2022-09-02 /pmc/articles/PMC9481304/ /pubmed/36119746 http://dx.doi.org/10.3389/fcvm.2022.956147 Text en Copyright © 2022 Stuckey, Meine, McMinn, Depta, Bennett, McGarry, Carroll, Suh, Steuter, Roberts, Gillins, Lange, Fathieh, Burton, Khosousi, Shadforth, Sanders and Rabbat. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Stuckey, Thomas
Meine, Frederick
McMinn, Thomas
Depta, Jeremiah P.
Bennett, Brett
McGarry, Thomas
Carroll, William
Suh, David
Steuter, John A.
Roberts, Michael
Gillins, Horace R.
Lange, Emmanuel
Fathieh, Farhad
Burton, Timothy
Khosousi, Ali
Shadforth, Ian
Sanders, William E.
Rabbat, Mark G.
Development and validation of a machine learned algorithm to IDENTIFY functionally significant coronary artery disease
title Development and validation of a machine learned algorithm to IDENTIFY functionally significant coronary artery disease
title_full Development and validation of a machine learned algorithm to IDENTIFY functionally significant coronary artery disease
title_fullStr Development and validation of a machine learned algorithm to IDENTIFY functionally significant coronary artery disease
title_full_unstemmed Development and validation of a machine learned algorithm to IDENTIFY functionally significant coronary artery disease
title_short Development and validation of a machine learned algorithm to IDENTIFY functionally significant coronary artery disease
title_sort development and validation of a machine learned algorithm to identify functionally significant coronary artery disease
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9481304/
https://www.ncbi.nlm.nih.gov/pubmed/36119746
http://dx.doi.org/10.3389/fcvm.2022.956147
work_keys_str_mv AT stuckeythomas developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT meinefrederick developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT mcminnthomas developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT deptajeremiahp developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT bennettbrett developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT mcgarrythomas developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT carrollwilliam developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT suhdavid developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT steuterjohna developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT robertsmichael developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT gillinshoracer developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT langeemmanuel developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT fathiehfarhad developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT burtontimothy developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT khosousiali developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT shadforthian developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT sanderswilliame developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease
AT rabbatmarkg developmentandvalidationofamachinelearnedalgorithmtoidentifyfunctionallysignificantcoronaryarterydisease